Enjoy complimentary customisation on priority with our Enterprise License!
The global bovine treatment system market size is estimated to grow by USD 3.82 billion at a CAGR of 5.51% between 2023 and 2028.
The cattle industry plays a significant role in providing meat and dairy products for human consumption. As the global population increases, so does the demand for animal products. This growth in the livestock industry necessitates effective veterinary treatment systems to maintain the health and productivity of cattle. Livestock provides a significant source of protein for human consumption. The global trend of urbanization has led to more people living in cities. Urban areas often have a higher demand for processed and convenience foods, which often contain animal products. Advances in agriculture and animal husbandry, including breeding, nutrition, and disease control, have improved the efficiency of livestock production, which is expected to drive the growth of the bovine treatment system market during the forecast period.
Technavio has segmented the market into Type, End-user and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The market share growth by the pharmaceutical and biologicals segment will be significant during the forecast period. Cattle are valuable assets in the agricultural industry, providing meat, milk, and other products. Drugs and vaccines that improve cattle health and productivity, such as growth promoters and fertility-enhancing medications, are in demand to maximize the return on investment for farmers. Farmers are increasingly focused on maintaining the health and well-being of their cattle.
Get a glance at the market contribution of various segments Download PDF Sample
The pharmaceutical and biologicals segment segment was the largest and was valued at USD 7.12 billion in 2018. A healthy herd is more productive and profitable. This drives the demand for drugs and vaccines that address specific health issues, such as respiratory diseases, gastrointestinal problems, and reproductive disorders. Vaccines and non-antibiotic treatment options are becoming more important in managing cattle health, especially in intensive livestock operations. The robust demand for drugs and vaccines for bovine treatment and prevention is expected to continue during the forecast period as the cattle industry strives to maintain the health, welfare, and productivity of livestock, meet regulatory requirements, and respond to consumer preferences for safer and more ethically produced meat and dairy products. Due to all such factors, the pharmaceutical and biologicals segment of the market is expected to grow during the forecast period.
Dairy farmers prioritize the health and well-being of their cattle, as healthy cows are more productive and produce higher-quality milk. Bovine treatment systems play a vital role in ensuring that cows are healthy and free from diseases. Regular veterinary care and health monitoring are essential in preventing diseases and addressing health issues early. The demand for bovine treatment systems in dairy farming is expected to continue to grow as the industry focuses on improving efficiency, animal health, and milk quality, which, in turn, will have a positive impact on the growth of the market during the forecast period.
Veterinary hospitals are one of the significant end-users of bovine treatment systems. These specialized facilities provide comprehensive veterinary care, including diagnostics, treatment, and surgical procedures, to a wide range of animals, including cattle. Veterinary hospitals are equipped with advanced diagnostic tools, such as radiography, ultrasonography, endoscopy, and laboratory equipment, which are essential for accurately diagnosing bovine conditions. Overall, veterinary hospitals are crucial end-users of bovine treatment systems as they offer a comprehensive range of veterinary services, advanced diagnostics, specialized care, and expertise in bovine health management, which is expected to boost the growth of the bovine treatment system market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. North America has a sizable and diverse cattle industry that includes both beef and dairy production. This diversity necessitates comprehensive healthcare and management solutions for cattle. There is a growing emphasis on the health and welfare of cattle in North America. Both consumers and producers are increasingly concerned about animal well-being, and bovine treatment systems are vital for maintaining high standards in these areas. Preventing diseases in cattle is a top priority for the North American cattle industry. Bovine treatment systems are used to implement vaccination programs, disease monitoring, and biosecurity measures to prevent and control diseases. Consumers in North America are increasingly interested in ethically raised and sustainably sourced beef and dairy products.
In addition, the demand for bovine treatment systems in North America is expected to continue to grow as the cattle industry evolves and adapts to changing consumer preferences, regulatory requirements, and sustainability objectives, which, in turn, will boost the growth of the regional bovine treatment system market during the forecast period.
The COVID-19 pandemic led to a decline in the growth of the bovine treatment system market in North America in 2020. In 2021, manufacturing facilities of monitoring equipment, drugs, and vaccines resumed operations with proper COVID-19 guidelines owing to the progressing vaccination drives in the region. Changing consumer preferences for ethically raised and sustainably sourced meat and dairy products continued to influence the cattle industry. Bovine treatment systems that support these practices are likely to gain traction. Thus, the regional demand for bovine treatment systems is increasing owing to the rise in concern for animal health, which is expected to boost the growth of the regional market during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Boehringer Ingelheim International GmbH - The company offers bovine treatment system such as Anafen injection 100mg or ML, Bio-Mycin 200, Bovikalc, and Cefa-Dri.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.
Animal welfare concerns are notably driving the market growth. There is a growing focus on the welfare of farm animals, including bovines. Consumers, animal rights organizations, and regulators are increasingly concerned about the ethical treatment of livestock. Veterinary treatment systems play a critical role in ensuring that cattle receive appropriate care, pain management, and disease prevention. Animal welfare advocates and farmers alike are increasingly focused on reducing stress and discomfort in cattle. Treatment systems that can manage pain, monitor stress levels, and provide comfort to animals are in demand. Ensuring cattle receive proper nutrition is a key aspect of animal healthcare.
Moreover, treatment systems may include features for monitoring and optimizing the nutritional needs of cattle, promoting better health and growth. Thus, the growing concern for animal health will have a positive impact on the growth of the global bovine treatment system market during the forecast period.
Technological advances in treatment method is an emerging trend shaping the market growth. Advances in technology have led to more sophisticated veterinary treatment systems. These systems may include digital diagnostic tools, telemedicine options, data analytics, and automated monitoring, making it easier to care for cattle efficiently. Diagnosis is an integral part of disease prevention and management, as a minor outbreak of disease can spread quickly and pose a threat to the entire population in the vicinity. Disease diagnosis of an animal forms the connecting link between the cause of and the cure for the disease.
However, there is a requirement for rapid methods that can provide answers related to disease in terms of its cause and the probable solution. Hence, diagnostic methods should fulfill the prerequisites of simplicity, speed, sensitivity, reproducibility, specificity, and low cost. Thus, the growing technological advancements will drive the growth of the market during the forecast period.
The regularity hurdle associated with animal drug development is a significant challenge hindering market growth. Animal healthcare drugs have to go through a rigorous approval process conducted by regulatory agencies, such as the U.S. Food and Drug Administration (FDA). This process involves extensive testing to demonstrate safety and efficacy. Manufacturers of animal healthcare drugs need to adhere to good manufacturing practices (GMP) standards to ensure the quality, safety, and consistency of their products. Regulations often require reporting of adverse events associated with the use of animal drugs. This helps monitor safety and identify potential issues.
Additionally, such regulations are intended to ensure that animal drugs are developed and manufactured to high standards of safety, efficacy, and quality. Compliance with these regulations is crucial for the responsible development, approval, and use of medications in animal healthcare. Thus, stringent regulation on drug development will hamper the growth of the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Bovine Treatment System Market Customer Landscape
The bovine treatment system market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
|
Bovine Treatment System Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
161 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.51% |
|
Market Growth 2024-2028 |
USD 3.82 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.88 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 39% |
|
Key countries |
US, Germany, UK, France, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Thermo Fisher Scientific Inc., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., and HIPRA S A |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Get the report (PDF) sent to your email within minutes.
